Isthmus Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.24M | Sell |
|
|||||
|
2025
Q1 | $3.96M | Sell |
|
|||||
|
2024
Q4 | $4.08M | Sell |
|
|||||
|
2024
Q3 | $3.86M | Sell |
|
|||||
|
2024
Q2 | $4.06M | Sell |
|
|||||
|
2024
Q1 | $3.53M | Buy |
|
|||||
|
2023
Q4 | $2.45M | Buy |
|
|||||
|
2023
Q3 | $1.97M | Buy |
|
|||||
|
2023
Q2 | $1.79M | Sell |
|
|||||
|
2023
Q1 | $1.83M | Buy |
|
|||||
|
2022
Q4 | $1.32M | Sell |
|
|||||
|
2022
Q3 | $1.71M | Buy |
|
|||||
|
2022
Q2 | $1.4M | Buy |
|
|||||
|
2022
Q1 | $1.66M | Buy |
|
|||||
|
2021
Q4 | $2.11M | Buy |
|
|||||
|
2021
Q3 | $1.88M | Buy |
|
|||||
|
2021
Q2 | $1.76M | Buy |
|
|||||
|
2021
Q1 | $2M | Sell |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|
|||||
|
2020
Q3 | $1.14M | Buy |
|
|||||
|
2020
Q2 | $1.22M | Buy |
|
|||||
|
2020
Q1 | $785K | Sell |
|
|||||
|
2019
Q4 | $1.19M | Buy |
|
|||||
|
2019
Q3 | $1.13M | Buy |
|
|||||
|
2019
Q2 | $1.12M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $936K | Buy |
|
|||||
|
2018
Q3 | $1.69M | Sell |
|
|||||
|
2018
Q2 | $1.38M | Sell |
|
|||||
|
2018
Q1 | $1.12M | Sell |
|
|||||
|
2017
Q4 | $942K | Sell |
|
|||||
|
2017
Q3 | $939K | Buy |
|
|||||
|
2017
Q2 | $835K | Sell |
|
|||||
|
2017
Q1 | $733K | Buy |
|
|||||
|
2016
Q4 | $688K | Sell |
|
|||||
|
2016
Q3 | $651K | Buy |
|
|||||
|
2016
Q2 | $805K | Sell |
|
|||||
|
2016
Q1 | $749K | Buy |
|
|||||
|
2015
Q4 | $757K | Buy |
|
|||||
|
2015
Q3 | $337K | Buy |
|
|||||
|
2015
Q2 | $394K | Buy |
|